Expression of miR-223 to predict outcomes after transcatheter aortic valve implantation.

Ceren EyiletenAlicja SkrobuchaMiłosz StarczyńskiMaria BoszkoJoanna Jarosz-PopekAlex FitasKrzysztof J FilipiakJanusz KochmanZenon HuczekBartosz RymuzaRadosław WilimskiMariusz KuśmierczykJolanta M Siller-MatulaMarek PostulaAleksandra Gąsecka

Published in: Cardiology journal (2022)

To conclude, miR-223 might improve risk stratification after TAVI. Further studies are required to confirm the clinical applicability of this promising biomarker.

Keyphrases

transcatheter aortic valve implantation
long non coding rna
aortic valve
cell proliferation
aortic valve replacement
aortic stenosis
poor prognosis
long noncoding rna
transcatheter aortic valve replacement
ejection fraction
left ventricular
coronary artery disease